ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts

March 28, 1980

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985